PPARG and irritable bowel syndrome: To further validate the effect of RCJ on the colitis model via microbiota-derived SCFAs/PPAR-γ, the RCJ + DSS treatment group showed increased expression, suggesting IBD might be correlated with PPAR-γ deficiency.